North Manchester General Hospital is a large NHS hospital in Crumpsall in the north of the English city of Manchester. It is operated by Manchester University NHS Foundation Trust on behalf of the Northern Care Alliance NHS Group.

There are 800 beds in North Manchester General Hospital.

During the past decade, North Manchester General Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 11 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Manchester General Hospital" #1 sponsor was "Gilead Sciences" with 11 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "Royal Marsden NHS Foundation Trust" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Manchester General Hospital" #1 collaborator was "Pelican Cancer Foundation" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Amarex Clinical Research" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "North Manchester General Hospital" are "Breast Cancer" (5 trials), "Colorectal Neoplasms" (3 trials), "Hepatitis C" (3 trials), "Hepatitis C, Chronic" (3 trials) and "Adenocarcinoma" (2 trials). Many other conditions were trialed in "North Manchester General Hospital" in a lesser frequency.

Most popular intervention types in "North Manchester General Hospital" are "Drug" (29 trials), "Other" (7 trials), "Procedure" (6 trials), "Biological" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "adjuvant therapy" (3 trials), "E/C/F/TAF" (2 trials), "E/C/F/TDF" (2 trials) and "EFV/FTC/TDF" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Manchester General Hospital" are 40 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "North Manchester General Hospital". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 27 completed trials in North Manchester General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in North Manchester General Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".